Open original FDA record ↗Recall record
- FDA identifier
- Z-0839-2007
- Company in FDA record
- EV3 Neurovascular
- FDA classification date
- Jun 7, 2007
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Two customer complaints were received from physicians in Japan indicating the hydrophilic coating was observed flaking from the guidewire while immersed in hydrating media following use during aneurysm embolization procedures.
Source facts
- Action
- A recall plan was developed for 100% recovery of guidewires within affected lot numbers. The plan includes notification to U.S., European, and Rest-of-World customers and distributors. A recall notification letter was prepared 04/05/2007 which summarizes the coating problem and potential risks, identifies the affected lot numbers and quantities shipped to the customer, and provides instructions for return of unused guidewires.
- Initiated
- 2007-04-05
- Root cause
- Other
- Terminated
- 2012-08-23
- Distribution
- Worldwide, including USA, Italy, United Kingdom, Switzerland, Germany, Belgium, South Africa, Canada, Slovenia, China, Austria, France, Spain, Jordan, Mexico, Portugal, Colombia, Greece, Brazil, Venezula, Ireland, Australia, Malaysia, Saudi Arabia, South Korea, Lithuania, Netherlands, Hungary, and United Arab Emirates
- Recall number
- Z-0839-2007
- Recall status
- Terminated
- CDRH record ID
- 51634
- FDA classified
- 2007-06-07
- Recall event number
- 37821